 Home > Medical News > Latest Medical News > Luoxin Pharmaceutical's new indications for ticolasheng tablets are approved to carry out clinical trials

Luoxin Pharmaceutical's new indications for ticolasheng tablets are approved to carry out clinical trials

 Last Update: 2021-07-29
 Source: Internet
 Author: User

Tags

green cotton fabric

celesta drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Following the introduction of Tigolasheng injection products, recently, Luoxin Pharmaceutical Group Co.

, Ltd.

Tigolasan is a Potassium-Competitive Acid Blockers (P-CAB).
As a new type of acid suppressant, P-CAB makes up for the traditional acid suppressant PPI that needs to undergo treatment.
Acid activation with short half-life and insufficient acid suppression lead to "pain points" such as low mucosal healing rate
.

Its mechanism of inhibiting acid secretion is to competitively bind to the potassium ion binding site of H+/K+-ATPase (proton pump) in mural cells, which can directly inhibit H+/K+-ATPase without activation in a strong acid environment

With continuous efforts in transformation, innovation and development, based on a rich product pipeline and strong R&D pipeline layout capabilities, Luoxin Pharmaceutical has successfully established a market position in core areas such as digestion and breathing, and has reserved a comprehensive and competitive product portfolio
.

At the same time as the introduction of ticolasheng injection, the clinical trial of new indications for ticolasheng tablets was approved, demonstrating Luoxin's strong R&D capabilities and clinical advancement capabilities, and looking forward to providing new options for acid suppression treatment as soon as possible

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.